Article
YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance
12 Feb 2024
Abstract excerpt
OBJECTIVE: Gastric cancer (GC) stands as a prevalent and deadly global malignancy. Despite its role as a preoperative neoadjuvant therapy, Apatinib's effectiveness is curtailed among GC patients exhibiting elevated YY1 expression. YY1's connection to adverse prognosis, drug resistance, and GC metastasis is established, yet the precise underlying mechanisms remain elusive. This study aims to unravel potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
